According to Health Canada (via FOI), this recall involved a device in Canada that was produced by MEDTRONIC OF CANADA LTD..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
  • Event Initiated Date
  • Event Country
  • Event Source
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Medtronic xomed is expanding the original product safety advisory for medtronic external nasal splints and thermasplints (incident 62165) to advise consignees to immediately discontinue using and dispose of the skin-prep protective wipes packed together with the affected medtronic nasal splint kits.The smith & nephew skin-prep protective wipes are contract manufactured by the triad group in the same facility where the alcohol wipes subject to the original field action are manufactured.


  • Model / Serial
    Model Catalog: 1529120 (Lot serial: ); Model Catalog: 1529110 (Lot serial: ); Model Catalog: 1528116 (Lot serial: ); Model Catalog: 1528126 (Lot serial: ); Model Catalog: 1528136 (Lot serial: ); Model Catalog: 1529100 (Lot serial: )
  • Product Description
    SKIN-PREP Protective Wipes
  • Manufacturer


  • Manufacturer Address
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source